Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)

Clinical trial NCT05540665 · TERMINATED

Trial details

NCT number: NCT05540665
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis

Start date: 2023-04-26
Primary completion: 2024-01-04
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.